Author response to: Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma

Br J Surg. 2022 Aug 16;109(9):e106. doi: 10.1093/bjs/znac160.

Arnaldo N S Silva^{1

2

3}, Yuichi Saito^{4

5}, Takaki Yoshikawa⁶, Takashi Oshima⁷, Jeremy D Hayden⁸, Jan Oosting⁹, Sophie Earle¹, Lindsay C Hewitt^{1

5}, Hayley L Slaney¹, Alex Wright¹, Imran Inam¹, Ruth E Langley¹⁰, William H Allum¹¹, Matthew G Nankivell¹⁰, Gordon Hutchins¹, David Cunningham¹², Heike I Grabsch^{1

5}

¹ Division of Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
² Department of Surgery, University of Cambridge, Cambridge University Hospitals, Addenbrookes, Cambridge, UK.
³ Cancer Research UK, Cambridge Institute, Cambridge, UK.
⁴ Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan.
⁵ Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands.
⁶ Department of Gastric Surgery, National Cancer Centre Hospital, Tokyo, Japan.
⁷ Department of Gastrointestinal Surgery, Kanagawa Cancer Centre Hospital, Yokohama, Japan.
⁸ Department of Upper Gastrointestinal Surgery, Institute of Oncology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
⁹ Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands.
¹⁰ MRC Clinical Trials Unit, University College London, London, UK.
¹¹ Department of Surgery, Royal Marsden Hospital, London, UK.
¹² Department of Medicine, Royal Marsden NHS Trust, London and Sutton, UK.

No abstract available

Publication types